Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
Objectives:. We aimed to describe the characteristics and outcome in children with severe Mycoplasma pneumoniae pneumonia in a Chinese PICU. Design:. A retrospective observational study from 2017 to 2019. Setting:. A 36-bed university tertiary PICU at Shanghai Children’s Hospital. Patients:. Patient...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e34cb04a26394359ab9f9fce7b667305 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e34cb04a26394359ab9f9fce7b667305 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e34cb04a26394359ab9f9fce7b6673052021-11-25T07:54:10ZCharacteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study2639-802810.1097/CCE.0000000000000366https://doaj.org/article/e34cb04a26394359ab9f9fce7b6673052021-03-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000366https://doaj.org/toc/2639-8028Objectives:. We aimed to describe the characteristics and outcome in children with severe Mycoplasma pneumoniae pneumonia in a Chinese PICU. Design:. A retrospective observational study from 2017 to 2019. Setting:. A 36-bed university tertiary PICU at Shanghai Children’s Hospital. Patients:. Patients admitted to a tertiary PICU 29 days to 18 years old screened for laboratory-confirmed severe M. pneumoniae pneumonia. Interventions:. None. Measurements and Main Results:. Descriptive analysis of baseline characteristics for patients included hospital mortality, organ dysfunctions, use of mechanical ventilation, continuous renal replacement therapy, and/or extracorporeal membrane oxygenation. A total of 817 children with severe pneumonia were admitted to PICU, and 203 of 817 cases (24.8%) with severe M. pneumoniae pneumonia were included in this study. The median age was 41 months (interquartile range, 20–67 mo), of which 77.3% (157/203) were younger than 6 years old. Among 163 patients with the test for macrolide resistance, 90.2% cases (147/163) were macrolide-resistant M. pneumoniae. Severe M. pneumoniae pneumonia-associated organ dysfunction included acute respiratory failure (203 cases, 100%), followed by cardiovascular disorder (79/203, 38.9%), gastrointestinal dysfunction (24/203, 11.8%). The main complications were pleural effusion (79/203, 38.9%), capillary leak syndrome (58/203, 28.6%), and plastic bronchitis (20/203, 9.9%). All patients needed respiratory support, including 64.5% patients (131/203) who received mechanical ventilation and 35.5% patients (72/203) who received high-flow nasal oxygen. Twenty-five patients (12.3%) treated with continuous renal replacement therapy and nine cases (4.4%) received extracorporeal membrane oxygenation. The case fatality rate was 3.9% (8/203). Furthermore, cardiovascular dysfunction, liver injury, or multiple organ dysfunction syndrome were associated with longer mechanical ventilation duration, delayed PICU discharge, and high hospital mortality. Coinfection was a risk factor of delayed PICU discharge. Conclusions:. Children with severe M. pneumoniae pneumonia mainly occur under the age of 6 years, showing a high proportion of extrapulmonary organ dysfunction and macrolide resistances. Extrapulmonary organ dysfunction and coinfection are associated with worse outcomes. The overall mortality is relatively low after treated with appreciate antibiotics, respiratory support, and extracorporeal life support.Yiping Zhou, MDYijun Shan, MDYun Cui, MDJingyi Shi, MD, PhDFei Wang, MDHuijie Miao, MDChunxia Wang, PhDYucai Zhang, PhDHari Krishnan KanthimathinathanRoddy O’DonnellMichelle JardineJo LumsdenJeremy TongAnand WaghPascale du PreAndrew NymanBogdana ZoicaRachel NealRebecca MittingKonstantinos DimitraidesClaire JenningsKaren CoxonCharlotte GoedvolkJames WeitzJade BryantJillian MacFadzeanAlastair TurnerWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 3, p e0366 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 |
spellingShingle |
Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Yiping Zhou, MD Yijun Shan, MD Yun Cui, MD Jingyi Shi, MD, PhD Fei Wang, MD Huijie Miao, MD Chunxia Wang, PhD Yucai Zhang, PhD Hari Krishnan Kanthimathinathan Roddy O’Donnell Michelle Jardine Jo Lumsden Jeremy Tong Anand Wagh Pascale du Pre Andrew Nyman Bogdana Zoica Rachel Neal Rebecca Mitting Konstantinos Dimitraides Claire Jennings Karen Coxon Charlotte Goedvolk James Weitz Jade Bryant Jillian MacFadzean Alastair Turner Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study |
description |
Objectives:. We aimed to describe the characteristics and outcome in children with severe Mycoplasma pneumoniae pneumonia in a Chinese PICU.
Design:. A retrospective observational study from 2017 to 2019.
Setting:. A 36-bed university tertiary PICU at Shanghai Children’s Hospital.
Patients:. Patients admitted to a tertiary PICU 29 days to 18 years old screened for laboratory-confirmed severe M. pneumoniae pneumonia.
Interventions:. None.
Measurements and Main Results:. Descriptive analysis of baseline characteristics for patients included hospital mortality, organ dysfunctions, use of mechanical ventilation, continuous renal replacement therapy, and/or extracorporeal membrane oxygenation. A total of 817 children with severe pneumonia were admitted to PICU, and 203 of 817 cases (24.8%) with severe M. pneumoniae pneumonia were included in this study. The median age was 41 months (interquartile range, 20–67 mo), of which 77.3% (157/203) were younger than 6 years old. Among 163 patients with the test for macrolide resistance, 90.2% cases (147/163) were macrolide-resistant M. pneumoniae. Severe M. pneumoniae pneumonia-associated organ dysfunction included acute respiratory failure (203 cases, 100%), followed by cardiovascular disorder (79/203, 38.9%), gastrointestinal dysfunction (24/203, 11.8%). The main complications were pleural effusion (79/203, 38.9%), capillary leak syndrome (58/203, 28.6%), and plastic bronchitis (20/203, 9.9%). All patients needed respiratory support, including 64.5% patients (131/203) who received mechanical ventilation and 35.5% patients (72/203) who received high-flow nasal oxygen. Twenty-five patients (12.3%) treated with continuous renal replacement therapy and nine cases (4.4%) received extracorporeal membrane oxygenation. The case fatality rate was 3.9% (8/203). Furthermore, cardiovascular dysfunction, liver injury, or multiple organ dysfunction syndrome were associated with longer mechanical ventilation duration, delayed PICU discharge, and high hospital mortality. Coinfection was a risk factor of delayed PICU discharge.
Conclusions:. Children with severe M. pneumoniae pneumonia mainly occur under the age of 6 years, showing a high proportion of extrapulmonary organ dysfunction and macrolide resistances. Extrapulmonary organ dysfunction and coinfection are associated with worse outcomes. The overall mortality is relatively low after treated with appreciate antibiotics, respiratory support, and extracorporeal life support. |
format |
article |
author |
Yiping Zhou, MD Yijun Shan, MD Yun Cui, MD Jingyi Shi, MD, PhD Fei Wang, MD Huijie Miao, MD Chunxia Wang, PhD Yucai Zhang, PhD Hari Krishnan Kanthimathinathan Roddy O’Donnell Michelle Jardine Jo Lumsden Jeremy Tong Anand Wagh Pascale du Pre Andrew Nyman Bogdana Zoica Rachel Neal Rebecca Mitting Konstantinos Dimitraides Claire Jennings Karen Coxon Charlotte Goedvolk James Weitz Jade Bryant Jillian MacFadzean Alastair Turner |
author_facet |
Yiping Zhou, MD Yijun Shan, MD Yun Cui, MD Jingyi Shi, MD, PhD Fei Wang, MD Huijie Miao, MD Chunxia Wang, PhD Yucai Zhang, PhD Hari Krishnan Kanthimathinathan Roddy O’Donnell Michelle Jardine Jo Lumsden Jeremy Tong Anand Wagh Pascale du Pre Andrew Nyman Bogdana Zoica Rachel Neal Rebecca Mitting Konstantinos Dimitraides Claire Jennings Karen Coxon Charlotte Goedvolk James Weitz Jade Bryant Jillian MacFadzean Alastair Turner |
author_sort |
Yiping Zhou, MD |
title |
Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study |
title_short |
Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study |
title_full |
Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study |
title_fullStr |
Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study |
title_full_unstemmed |
Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study |
title_sort |
characteristics and outcome of severe mycoplasma pneumoniae pneumonia admitted to picu in shanghai: a retrospective cohort study |
publisher |
Wolters Kluwer |
publishDate |
2021 |
url |
https://doaj.org/article/e34cb04a26394359ab9f9fce7b667305 |
work_keys_str_mv |
AT yipingzhoumd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT yijunshanmd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT yuncuimd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT jingyishimdphd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT feiwangmd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT huijiemiaomd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT chunxiawangphd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT yucaizhangphd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT harikrishnankanthimathinathan characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT roddyodonnell characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT michellejardine characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT jolumsden characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT jeremytong characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT anandwagh characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT pascaledupre characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT andrewnyman characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT bogdanazoica characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT rachelneal characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT rebeccamitting characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT konstantinosdimitraides characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT clairejennings characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT karencoxon characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT charlottegoedvolk characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT jamesweitz characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT jadebryant characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT jillianmacfadzean characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy AT alastairturner characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy |
_version_ |
1718413652784054272 |